ABDX
COM:ABINGDONHEALTH
Abingdon Health
- Stock
Last Close
7.25
22/11 15:15
Market Cap
143.03K
Beta: -
Volume Today
131.89K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|
net income | 3.47M - | -1.26M 136.32% | -3.37M 167.76% | -6.97M 106.67% | -21.26M 204.92% | -3.45M 83.77% | -1.27M 63.17% | |
depreciation and amortization | 680.74K - | 289.15K 57.52% | 225K 22.18% | 749K 232.89% | 1.64M 118.56% | 673K 58.89% | 426K 36.70% | |
deferred income tax | 1.06K - | 344.54K 32,251.27% | 14.94K 95.66% | -11.04M 74,002.57% | -8.86M 19.75% | 2.30M 125.93% | ||
stock based compensation | -1.42M - | 33.68K 102.37% | 36K 6.89% | 1.37M 3,697.22% | 231K 83.10% | 28K 87.88% | 48K 71.43% | |
change in working capital | -57.62K - | -279.15K 384.48% | 1.20M 530.60% | -8.18M 780.45% | -5.36M 34.49% | 3.67M 168.53% | -409K 111.14% | |
accounts receivables | 463.59K - | -460.29K 199.29% | 1.57M 442.17% | -8.10M 614.48% | 2.13M 126.34% | 6.65M 211.48% | -297K 104.47% | |
inventory | -133.09K - | -17.25K 87.04% | -373K 2,062.57% | -7.11M 1,805.90% | -2.32M 67.34% | 205K 108.83% | -112K 154.63% | |
accounts payables | -388.11K - | 198.39K 151.12% | 2.69M 1,255.83% | 7.03M 161.46% | -5.17M 173.51% | -3.18M 38.49% | -335K 89.47% | |
other working capital | -2.69M - | |||||||
other non cash items | -5.22M - | -36.40K 99.30% | 3.99M 11,065.04% | 11.20M 180.73% | 25.88M 130.99% | -2.22M 108.57% | -453K 79.58% | |
net cash provided by operating activities | -2.55M - | -908.25K 64.39% | 2.10M 330.66% | -12.88M 714.61% | -7.74M 39.93% | 1.00M 112.95% | -1.66M 265.57% | |
investments in property plant and equipment | -358.69K - | -96.22K 73.18% | -1.65M 1,614.87% | -7.25M 339.45% | -760K 89.52% | -157K 79.34% | -35K 77.71% | |
acquisitions net | 1.02K - | -175K 17,240.06% | -280K 60% | -24K 91.43% | -32K 33.33% | 1K 103.13% | ||
purchases of investments | -304 - | -13K - | ||||||
sales maturities of investments | ||||||||
other investing activites | 191.98K - | -8K 104.17% | 32K - | 12K - | ||||
net cash used for investing activites | -357.97K - | -79.24K 77.86% | -1.94M 2,345.70% | -7.28M 275.39% | -760K 89.55% | -156K 79.47% | -23K 85.26% | |
debt repayment | -900K - | -137K - | -251K 83.21% | -42K 83.27% | -135K 221.43% | -114K 15.56% | ||
common stock issued | 538.94K - | 1.50M 178.32% | 20.70M - | 6.14M 70.36% | ||||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 1.71M - | -123.26K 107.20% | 3.50M 2,941.10% | 289K 91.75% | -179K 161.94% | 128K 171.51% | -114K 189.06% | |
net cash used provided by financing activities | 1.35M - | 1.38M 1.92% | 3.37M 144.42% | 20.74M 516.34% | 5.92M 71.48% | -7K 100.12% | -114K 1,528.57% | |
effect of forex changes on cash | 866K - | -241 100.03% | ||||||
net change in cash | -1.56M - | 389.24K 124.99% | 3.52M 804.79% | 588.76K 83.28% | -2.58M 538.21% | 839K 132.52% | -1.80M 314.06% | |
cash at beginning of period | 2.03M - | 476.91K 76.56% | 866.15K 81.62% | 4.39M 406.64% | 4.98M 13.42% | 2.40M 51.84% | 3.24M 35.00% | |
cash at end of period | 476.91K - | 866.15K 81.62% | 4.39M 406.61% | 4.98M 13.42% | 2.40M 51.84% | 3.24M 35.00% | 1.44M 55.50% | |
operating cash flow | -2.55M - | -908.25K 64.39% | 2.10M 330.66% | -12.88M 714.61% | -7.74M 39.93% | 1.00M 112.95% | -1.66M 265.57% | |
capital expenditure | -358.69K - | -96.22K 73.18% | -1.65M 1,614.87% | -7.25M 339.45% | -760K 89.52% | -157K 79.34% | -35K 77.71% | |
free cash flow | -2.91M - | -1.00M 65.47% | 445K 144.30% | -20.13M 4,622.92% | -8.49M 57.79% | 845K 109.95% | -1.69M 300.47% |
All numbers in GBP (except ratios and percentages)